CAS: 19396-03-3; Polyoxin A

该化合物是天然抗风素化合物,通过发酵某些链球菌种,特别是链球菌,特别是链球菌,发酵产生天然抗风素,被归类为核肺侧抗生素,并因其能够抑制真菌细胞墙的关键组成部分 ----Chitin合成而闻名.这一行动机制使聚恶因A对各种真菌病原体有效,特别是在用作生物杀虫剂的农业环境中.该化合物的特点是对人类和动物的毒性相对较低,使其更安全地替代合成真菌剂.聚恶性A在酸性条件下溶于水中,并且具有稳定性,尽管可能在碱性环境中降解.其应用主要是在作物保护方面,它有助于控制真菌引起的疾病,从而有助于可持续农业做法.此外,目前的研究还探讨了它由于独特的生物化学特性,在包括制药和生物技术在内的其他领域的潜力.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-5110929-A
      优先权日:1986-08-07
      标题 :Process for the preparation of N-alkylated quaternary nitrogen containing aromatic heterocycles
      发明人:PARADIES HENRICH H
      权利人:MEDICE CHAM PHARM FABRIK PUTTE
      摘要:The synthesis of 4-, 4-(1,1)-and 3,5-substituted N-alkyl-pyridinium salts as well as of 2-carboxamide substituted N(1,4)diazinium compounds are described. The N-surfactants obtained have a small critical micelle concentration (CMC) of 10-5 -10-7 Mol/Liter. These surfactants produce micells of different size and form depending on the nature of the anions. 4-(1,1)-substituted and 3,5-substituted N-alkyl-pyridinium components are capable of forming vesicles in equeous solutions of different forms and sizes. The N-surfactants synthesized can be used as pharmaceuticals.

      专利号:US-5112844-A
      优先权日:1986-08-07
      标 题:Imidazole derivatives and use as anti-bacteria, anti-fungal and anti-viral agents
      发明人:PARADIES HENRICH H
      权利人:PUETTER MEDICE CHEM PHARM
      摘要:The synthesis of quaternary five membered N-n-alkyl-heterocycles, especially of 4-hydroxy-N(1)-n-alkyl-imidazolium, 2,5-substituted N(3)-n-alkyl-thiazolium and substituted N(2) pyrazolium salts are described. The N-surfactants obtained have a very small critical micelle concentration (CMC) of 10-5-10-7 Mol/Liter, and are capable of forming micelles of different sizes and forms depending on the nature of the anions. The N-detergents can be used as pharmaceuticals.

      专利号:US-5118808-A
      优先权日:1986-08-07
      标 题 :Pharmaceutical preparations
      发明人:PARADIES HENRICH H
      权利人:PUETTER MEDICE CHEM PHARM
      摘要:The synthesis and application of N(1)-n-alkyl-pyrimidinium-salts are described. These surfactants have a very small critical micelle concentration (CMC) in the order of 10 -5 -10 -7 Mol/Liter. These N(1)-n-alkyl-pyrimidinium components have pharmacological activities and can act as antimetabolites.

      专利号:US-5133973-A
      优先权日:1986-08-07
      标 题:Pharmaceutical preparations
      发明人:PARADIES HENRICH
      权利人:PUETTER MEDICE CHEM PHARM
      摘要:The synthesis and application of N(1)-n-alkyl-pyrimidinium-salts are described. These surfactants have a very small critical micelle concentration (CMC) in the order of 10-5-10-7 Mol/Liter. These N(1)-n-alkyl-pyrimidinium components have pharmacological activities and can act as antimetabolites.

      专利号:US-5057518-A
      优先权日:1986-08-07
      标题:Pharmaceutical preparations
      发明人:PARADIES HENRICH H
      权利人:MEDICE HEM PHARM FABRIK PUTTER
      摘要:The synthesis and application of N(1)-n-alkyl-pyrimidinium-salts are described. These surfactants have a very small critical micelle concentration (CMC) in the order of 10-5-10-7 Mol/Liter. These N(1)-n-alkyl-pyrimidinium components have pharmacological activities and can act as antimetabolites.

      专利号:US-5143917-A
      优先权日:1986-08-07
      标题 :Pharmaceutical preparations
      发明人:PARADIES HENRICH H
      权利人:PUETTER MEDICE CHEM PHARM
      摘要:The synthesis and application of N(1)-n-alkyl-pyrimidinium-salts are described. These surfactants have a very small critical micelle concentration ()CMC) in the order of 10-5-10-7 Mol/Liter. These N(1)-n-alkyl-pyrimidinium components have pharmacological activities and can act as antimetabolites.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Compound: Polyoxin A
      摘要:CRC Handbook of Antibiotic Compounds, Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980, 5(244), 1981
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知